ResearcherUniversity of Nebraska Medical CenterNo recent work listed
Saud Almawash
Matched on ORCID iD 0000-0001-8999-3464; OpenAlex author ID A5056786024. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2017: 1 paper · 2018: 1 paper
Papers 2
- Coadministration of Polymeric Conjugates of Docetaxel and Cyclopamine Synergistically Inhibits Orthotopic Pancreatic Cancer Growth and Metastasis. Co-author DOI 10.1007/s11095-017-2303-3↗
- EGFR-Targeted Cationic Polymeric Mixed Micelles for Codelivery of Gemcitabine and miR-205 for Treating Advanced Pancreatic Cancer. First author DOI 10.1021/acs.molpharmaceut.7b00355↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Goutam Mondal · 2 shared papers, 2017–2018 · strength 0.24
- Paper Coadministration of Polymeric Conjugates of Docetaxel and Cyclopamine Synergistically Inhibits Orthotopic Pancreatic Ca… DOI 10.1007/s11095-017-2303-3↗
- Paper EGFR-Targeted Cationic Polymeric Mixed Micelles for Codelivery of Gemcitabine and miR-205 for Treating Advanced Pancrea… DOI 10.1021/acs.molpharmaceut.7b00355↗
- Ram I. Mahato · 2 shared papers, 2017–2018 · strength 0.24
- Paper Coadministration of Polymeric Conjugates of Docetaxel and Cyclopamine Synergistically Inhibits Orthotopic Pancreatic Ca… DOI 10.1007/s11095-017-2303-3↗
- Paper EGFR-Targeted Cationic Polymeric Mixed Micelles for Codelivery of Gemcitabine and miR-205 for Treating Advanced Pancrea… DOI 10.1021/acs.molpharmaceut.7b00355↗
- Amit Chaudhary · 1 shared paper, 2017 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.